16
Participants
Start Date
November 30, 2011
Primary Completion Date
January 31, 2013
Study Completion Date
February 28, 2013
GRN1005
650 mg/m2 IV every 3 weeks
Univ. of Pittsburgh Medical Center, Pittsburgh
H. Lee Moffitt Cancer Center, Tampa
Tennessee Oncology, Nashville
Karmanos Cancer Institute, Detroit
Ingalls Memorial Hospital, Harvey
Northwestern Univ., Chicago
Univ. Coloardo at Denver, Aurora
Univ. of California San Diego, La Jolla
Dana Farber Cancer Institute, Boston
McGill Univ., Montreal
Lead Sponsor
Angiochem Inc
INDUSTRY